Latest Capital Raising Strategies News

Diablo Resources has completed the first tranche of a placement, raising $764,400 through 58.8 million shares at 1.3 cents each, with a shareholder meeting planned in June to approve a further $2.7 million raise.

McLaren Minerals reminds shareholders of the closing date for its discounted Share Purchase Plan, offering up to $30,000 in shares at $0.016 each. The capital raise supports ongoing development of its titanium and zircon projects in Australia.

Green Technology Metals (ASX: GT1) has initiated a fully underwritten $4 million entitlement offer to fund the next phase of its Seymour Lithium Project, alongside a $7 million placement subject to shareholder approval.

American Uranium Ltd (ASX:AMU) has initiated a non-renounceable entitlement issue to raise approximately AUD 2.59 million, primarily to advance exploration and development at its Lo Herma uranium project in Wyoming.

Contact Energy Limited has issued 4.99 million shares at NZ$9.42 each as scrip consideration to acquire a stake in King Country Energy. The shares will be escrowed for 12 months, marking a strategic expansion without a capital raise from existing shareholders.

European Resources Limited has withdrawn its March 2026 renounceable rights issue following shareholder feedback and market conditions, replacing it with a repriced April offer to raise approximately $3.4 million, underwritten for $1.5 million by Mahe Capital.

Kali Metals Limited (ASX:KM1) has finalised its Tranche 2 Placement, issuing 527,778 shares at A$0.18 each and raising approximately A$95,000 following shareholder approval.

EVE Health Group has announced a $1.3 million capital raising through a placement of shares and free attaching options, aimed at advancing its pharmaceutical product rollout and development pipeline. Several components of the offer await shareholder approval at an upcoming general meeting.

Genesis Energy has opened a NZ$300 million rights offer priced at NZ$2.05 per share, marking a 10.8% discount to the theoretical ex-rights price, aiming to accelerate its growth pipeline following a recent NZ$100 million placement.

Ardea Resources has successfully raised A$5 million through a placement and launched a A$2 million Share Purchase Plan to fund the next phase of its Kalgoorlie Nickel Project. The capital injection supports the finalisation of a key feasibility study and ongoing project development.

Racura Oncology reported a $4.1 million loss for H1 FY26, reflecting heavy investment in clinical trials and intellectual property. The company also boosted cash reserves through capital raises and rebranded from Race Oncology.

Identitii Limited faces a setback as Beauvais Capital terminates its underwriting agreement following Takeovers Panel orders, triggering shareholder withdrawal rights and uncertainty over the company’s capital raising plans.